Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Sannuo Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical manufacturer and one of the world's largest producers of xanthine-based active pharmaceutical ingredients (APIs). The company specializes in the high-volume production of caffeine, theophylline, and aminophylline, serving as a critical supplier to the global pharmaceutical, beverage, and nutritional industries. As a key subsidiary of the Honggang Group, Hebei Sannuo operates large-scale, GMP-compliant facilities and exports its products to over 60 countries worldwide. While primarily known for its dominant position in the caffeine market, the company also manufactures finished dosage forms for respiratory and cardiovascular indications, maintaining a robust role in the global healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Sannuo Pharmaceutical.